Is BOLT stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Bolt Biotherapeutics, pays dividends. Last time was Thursday 2nd of October 2014 where the investors holding the stock on Friday 29th of August 2014 were paid $0.09000 per share. Over the last 11 times between 2012 and 2014, Bolt Biotherapeutics, has paid $0.83 with an average of $0.08 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Bolt Biotherapeutics, 10 years ago, but if you had invested on Friday 5th of February 2021 when the price was $32.15, you would have made a loss of $-31.51 per share or -98.01%
No, the average daily trading liquidity for Bolt Biotherapeutics, is $167 214 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Bolt Biotherapeutics, has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Bolt Biotherapeutics, to be high [0.85 out of 1]